Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with…
Recalling firm: Novacare, LLC
TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Mar 27, 2017.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot #s: 4102801, 2071918.2, 2061401, 2032006
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with meals
Original FDA recall reason
TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.
Recall details
- Recall number
- F-2946-2015
- Event ID
- 71664
- FDA status
- Terminated
- Initiated
- May 27, 2015
- Reported
- Aug 19, 2015
- Classified
- Aug 11, 2015
- Terminated
- Mar 27, 2017
- Quantity
- 961 bottles.
- Location
- Murray, UT, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Nationwide. No foreign or VA/govt/military consignees.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.